BEVERLY, MA and TORONTO, ON--(Marketwired - Jan 5, 2015) -  Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the commercial release of its easy to use and cost-effective Remote Capture station for its industry-leading Computer Assisted Sperm Analysis (CASA) systems.

The Remote Capture station is a standalone video capture system that allows fertility clinics to expand services offered in their satellite laboratories. The system enables remote laboratories to save sperm motility videos for analysis and custom report creation on an IVOS II or CEROS II analyzer at their central facility. Patient identification, system settings and sample information are saved along with the video for tracking and quality control. Once captured, videos are easily transmitted via physical media, over the clinic's own network or over the Internet using email or through cloud-based file transfer services.

"We created the Remote Capture capability in direct response to customer requests for convenient, lower-cost sperm analysis solutions geared towards multi-site clinics," commented David Wolf, President and CEO of Hamilton Thorne. "With our intuitive software featuring proprietary interactive illumination controls and immediate video feedback, clinics will feel confident in the ability of their satellite laboratories to capture the highest quality video images for sperm analysis." 

A complete remote capture station includes software, high resolution digital camera and PC, and is offered with or without microscope. Additional information may be found at

Certain products listed above are available for research only purposes in the United States.

About Hamilton Thorne Ltd. (
Hamilton Thorne designs, manufactures and distributes precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets. It provides novel solutions for Life Science that reduce cost, increase productivity, improve results and enable research breakthroughs in fertility, regenerative medicine, and stem cell research markets. Hamilton Thorne's laser products attach to standard inverted microscopes and operate as robotic micro-surgeons, enabling a wide array of scientific applications and IVF procedures. Its imaging systems improve outcomes in human IVF clinics and animal breeding facilities and provide high-end toxicology analyses. 

The Company's growing customer base includes pharmaceutical companies, biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Current customers include world-leading research labs such as Harvard, MIT, Yale, McGill, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, and Oxford and Cambridge.

Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.

Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available at

Contact Information:

For more information, please contact:

David Wolf
President & CEO
Hamilton Thorne Ltd.

Michael Bruns
Hamilton Thorne Ltd.